Clinical Trial Update: Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical study evaluating the early bactericidal activity of contezolid against Mycobacterium abscessus infection, currently enrolling by invi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Infection

Drugs mentioned

• Contezolid (contezolid)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Monotherapy, Mycobacterium Abscessus Infection | Phase 2 | Status: ENROLLING_BY_INVITATION